Category: Position statements

Here is an opinion from the Professional Council of Diabetes Québec (PCDQ) on the efficacy of biosimilar insulins for the treatment of diabetes.

Press release from the Professional Council of Diabetes Québec For several weeks, Quebec has been affected by a supply problem that began with semaglutide (Ozempic®) injectable pens. This is a worldwide shortage due to the high demand for diabetes and obesity treatment. As a result, intermittent stockouts are expected until April 2024 in Canada for…

Diabetes Québec believes that preventive measures must be put in place to reduce the pressure on the health care system and promote the health and well-being of the population in Québec. The collateral effects of the pandemic on lifestyle habits, such as physical activity and diet, suggest worrying consequences on health. In 2020, Diabetes Quebec…

Diabetes Québec and its Professional Council have once again taken a position on COVID-19 vaccination for people with diabetes. Here are the details. New priority groups Until recently, people under the age of 60 living with a chronic disease (including diabetes) were in group 8 in the order of priority for a vaccination. This group…

Given the debate surrounding the tax credits for the benefit of people with insulin-dependent diabetes, Diabetes Québec and its Professional Council have expressed their opinion on the subject. What are these tax credits? There are non-refundable tax credits for people living with a severe and prolonged impairment that people living with insulin-dependent diabetes can benefit…

People suffering from a chronic disease, like diabetes, should be able to get a COVID-19 vaccination as soon as possible.